Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620392
Title:
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Authors:
James, N D; de Bono, J S; Spears, M R; Clarke, NW; Mason, M D; Dearnaley, D P; Ritchie, A W S; Amos, C L; Gilson, C; Jones, R J; Matheson, D; Millman, R; Attard, G; Chowdhury, S; Cross, W R; Gillessen, S; Parker, C C; Russell, J M; Berthold, D R; Brawley, C; Adab, F; Aung, San; Birtle, A J; Bowen, J; Brock, S; Chakraborti, P; Ferguson, C; Gale, J; Gray, E; Hingorani, M; Hoskin, P J; Lester, J F; Malik, Z I; McKinna, F; McPhail, N; Money-Kyrle, J; O'Sullivan, J; Parikh, O; Protheroe, A; Robinson, A; Srihari, N N; Thomas, C; Wagstaff, J; Wylie, J; Zarkar, A; Parmar, M K B; Sydes, M R
Abstract:
Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial design.
Citation:
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. 2017, 377 (4):338-351 N. Engl. J. Med.
Publisher:
New England Journal of Medicine
Journal:
The New England journal of medicine
Issue Date:
Jul-2017
URI:
http://hdl.handle.net/11287/620392
DOI:
10.1056/NEJMoa1702900
PubMed ID:
28578639
Additional Links:
http://www.nejm.org/doi/abs/10.1056/NEJMoa1702900?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Type:
Journal Article
Language:
en
ISSN:
1533-4406
Appears in Collections:
Oncology; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorJames, N Den
dc.contributor.authorde Bono, J Sen
dc.contributor.authorSpears, M Ren
dc.contributor.authorClarke, NWen
dc.contributor.authorMason, M Den
dc.contributor.authorDearnaley, D Pen
dc.contributor.authorRitchie, A W Sen
dc.contributor.authorAmos, C Len
dc.contributor.authorGilson, Cen
dc.contributor.authorJones, R Jen
dc.contributor.authorMatheson, Den
dc.contributor.authorMillman, Ren
dc.contributor.authorAttard, Gen
dc.contributor.authorChowdhury, Sen
dc.contributor.authorCross, W Ren
dc.contributor.authorGillessen, Sen
dc.contributor.authorParker, C Cen
dc.contributor.authorRussell, J Men
dc.contributor.authorBerthold, D Ren
dc.contributor.authorBrawley, Cen
dc.contributor.authorAdab, Fen
dc.contributor.authorAung, Sanen
dc.contributor.authorBirtle, A Jen
dc.contributor.authorBowen, Jen
dc.contributor.authorBrock, Sen
dc.contributor.authorChakraborti, Pen
dc.contributor.authorFerguson, Cen
dc.contributor.authorGale, Jen
dc.contributor.authorGray, Een
dc.contributor.authorHingorani, Men
dc.contributor.authorHoskin, P Jen
dc.contributor.authorLester, J Fen
dc.contributor.authorMalik, Z Ien
dc.contributor.authorMcKinna, Fen
dc.contributor.authorMcPhail, Nen
dc.contributor.authorMoney-Kyrle, Jen
dc.contributor.authorO'Sullivan, Jen
dc.contributor.authorParikh, Oen
dc.contributor.authorProtheroe, Aen
dc.contributor.authorRobinson, Aen
dc.contributor.authorSrihari, N Nen
dc.contributor.authorThomas, Cen
dc.contributor.authorWagstaff, Jen
dc.contributor.authorWylie, Jen
dc.contributor.authorZarkar, Aen
dc.contributor.authorParmar, M K Ben
dc.contributor.authorSydes, M Ren
dc.date.accessioned2017-09-08T14:26:44Z-
dc.date.available2017-09-08T14:26:44Z-
dc.date.issued2017-07-
dc.identifier.citationAbiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. 2017, 377 (4):338-351 N. Engl. J. Med.en
dc.identifier.issn1533-4406-
dc.identifier.pmid28578639-
dc.identifier.doi10.1056/NEJMoa1702900-
dc.identifier.urihttp://hdl.handle.net/11287/620392-
dc.description.abstractAbiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial design.en
dc.language.isoenen
dc.publisherNew England Journal of Medicineen
dc.relation.urlhttp://www.nejm.org/doi/abs/10.1056/NEJMoa1702900?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmeden
dc.rightsArchived with thanks to The New England journal of medicineen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.en
dc.titleAbiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.en
dc.typeJournal Articleen
dc.identifier.journalThe New England journal of medicineen
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.